September 24, 2014
A D.C. federal judge on Tuesday tossed a lawsuit brought by U.S. Food and Drug Administration scientists who claimed their private emails were monitored after they reported that allegedly unsafe medical devices were being approved, saying the scientists had to first exhaust their options for administrative relief.
February 26, 2014
The U.S. Food and Drug Administration failed to explore legal implications before surveilling its scientists' online activities to determine who was leaking the trade secrets of medical device makers as part of whistleblowing about safety concerns, the U.S. Government Accountability Office said Tuesday.
October 02, 2012
The U.S. Food and Drug Administration on Monday asked a Washington federal judge to dismiss a lawsuit brought by FDA scientists who claim their private emails were monitored after they reported approvals of allegedly unsafe medical devices, saying the plaintiffs had failed to exhaust their administrative options.
July 23, 2012
A Washington federal judge on Monday ordered the U.S. Food and Drug Administration to turn over documents requested by FDA scientists who claim the agency secretly monitored their private emails after they reported approvals of what they believed were unsafe medical devices.
March 06, 2012
Sen. Chuck Grassley, R-Iowa, and Rep. Darrell Issa, R-Calif., asked the Obama administration Monday to determine federal agencies' polices regarding the monitoring of employee emails, citing concerns about whistleblower intimidation following allegations that the U.S. Food and Drug Administration wrongly monitored whistleblowers' emails.
February 02, 2012
Sen. Chuck Grassley, R-Iowa, is launching an investigation into whether the U.S. Food and Drug Administration improperly retaliated against employees who reported that the agency was approving what they believed were unsafe medical devices, the senator said Thursday.
January 30, 2012
The U.S. Food and Drug Administration violated several FDA scientists' free speech and search and seizure rights by secretly monitoring their private emails after they had sent a letter to the Obama administration claiming the agency was improperly approving risky medical devices, according to a complaint filed Wednesday.